Entasis Therapeutics Holdings Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ETTX research report →
About the company
Entasis Therapeutics Holdings Inc. operates as a clinical-stage biopharmaceutical enterprise, dedicated to the discovery, development, and market introduction of novel antibacterial solutions. Their core mission in the United States is to address severe infections stemming from pathogens that exhibit multidrug resistance.
- CEO
- Manoussos Perros
- IPO
- 2018
- Employees
- 51
- HQ
- Waltham, MA, US
Price Chart
- Market Cap
- $0
- P/E
- -2.19
- P/S
- 0.00
- P/B
- 3.32
- EV/EBITDA
- 0.69
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -112.91%
- ROIC
- -151.03%
- Revenue
- $0 · 0.00%
- Net Income
- $-47,141,000 · 6.64%
- EPS
- $-1.00 · 52.38%
- Op Income
- $-47,141,000
- FCF YoY
- 5.29%
- Beta
- 1.33
Get TickerSpark's AI analysis on ETTX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 8, 22 | Innoviva Strategic Opportunities LLC | buy | 7,598,814 |
| Jul 11, 22 | Tommasi Ruben | other | 24,858 |
| Jul 11, 22 | Tommasi Ruben | other | 6,465 |
| Jul 11, 22 | Tommasi Ruben | other | 50,000 |
| Jul 7, 22 | Tommasi Ruben | other | 39,596 |
| Jul 11, 22 | Tommasi Ruben | sell | 150,000 |
| Jul 11, 22 | Tommasi Ruben | other | 98,700 |
| Jul 11, 22 | Perros Manoussos | other | 69,970 |
| Jul 7, 22 | Perros Manoussos | other | 56,072 |
| Jul 11, 22 | Perros Manoussos | other | 325,755 |
Our ETTX coverage
Recent articles, reports, and earnings notes.
No research on ETTX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ETTX report →Similar companies
Peers in the same neighborhood.